Simpler antibiotics for uncomplicated bone and joint infections in children
Part of Bones, joints & muscles, Infections clinical trials.
This trial looks at whether a simpler antibiotic plan can work for children with uncomplicated bone or joint infections that start in the community. It may help reduce the need for complicated treatment while still keeping the infection under control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 and 18 years old
- The bone or joint infection is acute, uncomplicated, and started outside the hospital
- The infection is not caused by bacteria resistant to cephalexin, and it is not an atypical infection (like fungal or mycobacterial)
- Your child does not have signs of severe body-wide illness from infection (sepsis) or organ problems
- Your child has no severe complications like necrotizing fasciitis or other hard-to-treat conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if starting treatment for uncomplicated bone or joint infections in children with oral (by mouth) antibiotics is effective. It focuses on kids who are not severely ill and do not have certain risk factors, and who can begin oral antibiotics right away or after a short course of IV (intravenous) antibiotics.
This study compares two oral antibiotics, TMP-SMX and clindamycin, to see which works better for children with MRSA infections in bones, joints, or head/neck areas. It aims to find the best treatment after initial IV therapy.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This trial tests whether giving antibiotics can prevent infections in children with mild open fractures (grade 1 or 2) that don't need surgery. It aims to find a safer, simpler treatment plan.
This trial tests whether one dose of intravenous (IV) antibiotics is as effective as the usual multiple-dose course for children with complicated urinary tract infections (UTIs) who need IV treatment in the emergency department. It aims to reduce hospital stays and the need for repeated IV lines.
This study tests a new IV antibiotic combination (cefepime-enmetazobactam) for children with complicated urinary tract infections or kidney infections. The goal is to see how well it works and if it is safe.
Hear when a new Bone Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.